Illumina, Inc. (ILMN) Upgraded to Strong-Buy by Vetr Inc.

Illumina, Inc. (ILMN) Upgraded to Strong-Buy by Vetr Inc.


The brokerage currently has a $187.82 price objective on the life sciences company's stock. Vetr 's price objective would suggest a potential upside of 10.11% from the stock's current price.



from Biotech News